SINGULUS TECHNOLOGIES receives follow-on order for medical technology - another processing plant for processing of contact lenses ordered
SINGULUS TECHNOLOGIES receives follow-on order for medical technology - another processing plant for processing of contact lenses ordered Kahl am Main, 13 June 2018 - SINGULUS TECHNOLOGIES AG (SINGULUS TECHNOLOGIES) has signed a contract to supply a further processing plant for the manufacture of contact lenses. The successful entry of SINGULUS TECHNOLOGIES into medical technology last year signalled a strategically important broadening of its portfolio.
The new contract, which follows on from the first order last November with a volume of more than ten million euros, further cements the position of SINGULUS TECHNOLOGIES in the increasingly important market of medical technology. All systems ordered will be supplied to an internationally active company in the medical sector.
SINGULUS TECHNOLOGIES has been working together with that customer on development projects for some time now, and has developed a new processing system for the manufacture of contact lenses. The new "MEDLINE Clean" system cleans residual material from contact lenses and then coats the lenses in a further process step. The production system is modular in design and can be used for a wide range of applications, including beyond ophthalmics. Medical products with a wide range of formats can be processed.
For medical technology, SINGULUS TECHNOLOGIES offers machine technology for wet-chemical processes and vacuum coating processes as well as injection-molding of small plastic parts where high precision and extremely high quality are required. A common trait of all processes is the basic principle of efficient, low-resource production technology.
SINGULUS TECHNOLOGIES - innovations for new technologies SINGULUS TECHNOLOGIES builds innovative machines and equipment for economical and resource-efficient production processes.
These core competencies comprise coating technology, surface processing, wet-chemical applications as well as thermal processing steps. The company provides machines that are used in the solar, semiconductor technology, medical technology, consumer goods and optical disc areas worldwide. For all machines, processes and applications SINGULUS TECHNOLOGIES draws upon its know-how in the areas of automation and process technology.
Contact: SINGULUS TECHNOLOGIES AG, Hanauer Landstraße 103, 63796 Kahl am Main, Germany, Maren Schuster, Investor Relations, Tel.: + 49 (0)160 9609 0279 Bernhard Krause, Corporate Communications, Tel.: + 49 (0)170 9202924
13.06.2018 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.deLanguage: English Company: SINGULUS TECHNOLOGIES AG Hanauer Landstrasse 103 63796 Kahl am Main
Germany Phone: +49 (0)1709202924 Fax: +49 (0)6188 440-110 E-mail: firstname.lastname@example.org Internet: www.singulus.de ISIN: DE000A1681X5, DE000A2AA5H5 WKN: A1681X, A2AA5H Listed: Regulated Market in Berlin, Frankfurt (Prime Standard); Regulated Unofficial Market in Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange End of News DGAP News Service